Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
about
Vitamin C and Vitamin E for Alzheimer's DiseaseNeuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathwaysMicroglial cell dysregulation in brain aging and neurodegenerationThe Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliationEntorhinal cortical defects in Tg2576 mice are present as early as 2-4 months of age.Vitamin Supplementation as an Adjuvant Treatment for Alzheimer's DiseaseThe Impact of Vitamin E and Other Fat-Soluble Vitamins on Alzheimer´s DiseaseNeuroprotective properties of the marine carotenoid astaxanthin and omega-3 fatty acids, and perspectives for the natural combination of both in krill oilCharacterizing the novel protein p33MONOXAcetaminophen inhibits neuronal inflammation and protects neurons from oxidative stressP2Y2 nucleotide receptor-mediated responses in brain cells.Peierls-Nabarro barrier and protein loop propagation.A heme oxygenase-1 transducer model of degenerative and developmental brain disorders.Implications of protein structure instability: from physiological to pathological secondary structure.Chronic intermittent fasting improves cognitive functions and brain structures in mice.The use of mouse models to understand and improve cognitive deficits in Down syndrome.Inflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood-brain barrier: protection by the antioxidant N-acetylcysteine.Protective effects of compound FLZ on beta-amyloid peptide-(25-35)-induced mouse hippocampal injury and learning and memory impairment.The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation.Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's diseaseMedial septal beta-amyloid 1-40 injections alter septo-hippocampal anatomy and function.Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis.Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.Site-specific protein adducts of 4-hydroxy-2(E)-nonenal in human THP-1 monocytic cells: protein carbonylation is diminished by ascorbic acid.Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease.Aconitase and ATP synthase are targets of malondialdehyde modification and undergo an age-related decrease in activity in mouse heart mitochondria.Brain endothelial cells synthesize neurotoxic thrombin in Alzheimer's disease.The expression of apoptosis inducing factor (AIF) is associated with aging-related cell death in the cortex but not in the hippocampus in the TgCRND8 mouse model of Alzheimer's disease.Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases.YAP accelerates Aβ(25-35)-induced apoptosis through upregulation of Bax expression by interaction with p73.Despite its role in assembly, methionine 35 is not necessary for amyloid beta-protein toxicityOxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegenerationTherapeutic approaches to delay the onset of Alzheimer's diseaseAdipose and leptomeningeal arteriole endothelial dysfunction induced by β-amyloid peptide: a practical human model to study Alzheimer's disease vasculopathyBioactive compounds from macroalgae in the new millennium: implications for neurodegenerative diseases.Free radicals, antioxidants in disease and health.Amyloid β levels in human red blood cellsAn update on using vitamin E in Alzheimer's disease.The protein oxidation repair enzyme methionine sulfoxide reductase a modulates Aβ aggregation and toxicity in vivo.PARP-1 modulates amyloid beta peptide-induced neuronal damage.
P2860
Q22241556-444DDA6D-702B-488B-9C7A-22718B03155FQ26779424-2BB98C80-CFDF-4679-9300-0F2F9DE48650Q26800212-34FC864A-FB84-4383-8A67-9722AEFC4E36Q26823454-3C69606B-F48F-4E7E-91CD-FA29EED12B91Q27307826-EED14D77-0209-4C7A-8A19-27F31DC2625DQ28073374-B8C55003-B37E-4150-9AD6-592B9B13DA8CQ28074531-4AE7C667-37B3-4437-A171-0256DE3D1527Q28236740-1C906891-41F0-4002-9408-F6AA12E2D912Q28509587-FA9473DB-04DD-4B65-A10C-775B28725693Q28576204-4291EE74-435E-4058-9C6B-591417510719Q30156903-F4D9A0C8-BBD6-465A-9E7E-16B835D0D6CFQ30371027-B90EEDD6-4CAE-4471-A367-6789683BB298Q30411177-8DC5C020-FFA0-4F84-85D1-70B80BBD6534Q30416896-1A9FA00B-9125-42B3-8877-84B9B80AC4D8Q30418840-593C780C-9136-4C23-822E-809F862D48BCQ30474023-D63A337A-93B1-4FC6-B297-DA83FEF2532FQ30524688-70F6FAAF-EE82-40E1-A951-A9289CF4A227Q33244612-AC85A3A3-AD4F-4B9B-ABF2-5EEFCD3F83F3Q33272109-7C16F36A-6876-4296-BE9D-355669C052EFQ33494148-E4C5A20E-B260-4642-A1CB-5E0075DB8A70Q33605897-2111EA16-E3B1-4486-84E5-DA937B39ED6CQ33607471-DF26F96E-026B-423A-96C5-59041D5841DDQ33639885-FDF55298-4EBB-4232-B77B-0D069E3A64EFQ33674371-7A0F07AE-3FDA-47C1-BD9B-42AEDF46FC94Q33712475-305F2BF7-9949-4CB9-9D9A-4A4E751CDD0CQ33721616-5CCC49C2-25C9-4F00-9567-62E3A7AF1CADQ33745087-DD931270-2DF6-4659-81CB-758AFEC46C2AQ33803360-62DD366B-B610-4F1B-8288-E639CCB028B1Q33891870-1AB34569-B1D4-4399-891E-CD624FD0645FQ33896065-02A3CEBD-C355-460F-B368-C6F870DAF750Q34012473-63562FE3-5F1E-4B8C-A343-B71B48701405Q34071097-18283194-D4B9-454B-B266-79AD75112B4DQ34172377-6C6B55BF-B1A3-4AC8-88B2-3296C6A76F41Q34246785-618A606A-C05B-4373-BA62-EC8063E0287CQ34260323-60B6ED83-37D2-4996-980F-36415D1F067DQ34344766-1B8998E5-8855-462C-A26F-2B15E39582E2Q34482602-EFAD33DB-4FFB-458A-84A8-81A97268BEDDQ34616619-FE0E5F12-06A0-414C-A3B2-AC83E9E49585Q34729853-A904E858-692D-4F86-B746-4BB4DE29B231Q35004641-2A1CF9F6-8577-4FD2-AD5F-31622FEBF16C
P2860
Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Amyloid beta-peptide (1-42)-in ...... mer's disease brain. A review.
@ast
Amyloid beta-peptide (1-42)-in ...... mer's disease brain. A review.
@en
type
label
Amyloid beta-peptide (1-42)-in ...... mer's disease brain. A review.
@ast
Amyloid beta-peptide (1-42)-in ...... mer's disease brain. A review.
@en
prefLabel
Amyloid beta-peptide (1-42)-in ...... mer's disease brain. A review.
@ast
Amyloid beta-peptide (1-42)-in ...... mer's disease brain. A review.
@en
P1476
Amyloid beta-peptide (1-42)-in ...... mer's disease brain. A review.
@en
P304
P356
10.1080/1071576021000049890
P577
2002-12-01T00:00:00Z